Identification of Pancreatic Cancer-Associated Tumor Antigen from HSP-Enriched Tumor Lysate-Pulsed Human Dendritic Cells

키워드

참고문헌 (80)

1. Berger TG, "Large-scale generation of mature monocyte-derived dendritic cells for clinical application in cell factories", J Immunol Methods, 268, pp.131~140 (2002)
2. Kim S, "Monocyte enrichment from leukapheresis products by using the Elutra cell separator", Transfusion, 47, pp.2290~2296 (2007)
3. Schreurs MW, "Dendritic cells break tolerance and induce protective immunity against a melanocyte differentiation antigen in an autologous melanoma model", Cancer Res, 60, pp.6995~7001 (2000)
4. Hofmann S, "Rapid and sensitive identification of major histocompatibility complex class I-associated tumor peptides by Nano-LC MALDI MS", MS, 2005, pp.4, 1888~1897
5. Ridge JP, "A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell", Nature, 393, pp.474~478 (1998)
6. Hu HM, "Divergent roles for CD4+ T cells in the priming and effector", memory phases of adoptive immunotherapy, 2000, pp.165, 4246~4253
7. Wang RF, "The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity", Trends Immunol, 22, pp.269~276 (2001)
8. Schuurhuis DH, "Immature dendritic cells acquire CD8(+) cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli", J Exp Med, 192, pp.145~150 (2000)
9. Melief CJ, "Effective therapeutic anticancer vaccines based on precision guiding of cytolytic T lymphocytes", Immunol Rev, 188, pp.177~182 (2002)
10. Dolan BP, "Tumor-specific CD4+ T cells are activated by “cross-dressed” dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines", J Immunol, 176, pp.1447~1455 (2006)
11. Parmiani G, "Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?", J Natl Cancer Inst, 94, pp.805~818 (2002)
12. Admon A, "Tumor antigens and proteomics from the point of view of the major histocompatibility complex peptides", Mol Cell Proteomics, 2, pp.388~398 (2003)
13. Fields RC, "Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo", Proc Natl Acad Sci U S A, 95, pp.9482~9487 (1998)
14. Nestle FO, "Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells", Nat Med, 4, pp.328~332 (1998)
15. Schnurr M, "Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines", Cancer Res, 61, pp.6445~6450 (2001)
16. Yu JS, "Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma", Cancer Res, 64, pp.4973~4979 (2004)
17. Geiger JD, "Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression", Cancer Res, 61, pp.8513~8519 (2001)
18. Höltl L, "Immunotherapy of metastatic renal cell carcinoma with tumor lysate-pulsed autologous dendritic cells", Clin Cancer Res, 8, pp.3369~3376 (2002)
19. Hatfield P, "Optimization of dendritic cell loading with tumor cell lysates for cancer immunotherapy", J Immunother, 31, pp.620~632 (2008)
20. Sauter B, "Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells", J Exp Med, 191, pp.423~434 (2000)
21. Kotera Y, "Comparative analysis of necrotic and apoptotic tumor cells as a source of antigen(s) in dendritic cell-based immunization", Cancer Res, 61, pp.8105~8109 (2001)
22. Galea-Lauri J, "Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination", Cancer Immunol Immunother, 53, pp.963~967 (2004)
23. Steinman RM, "The induction of tolerance by dendritic cells that have captured apoptotic cells", J Exp Med, 191, pp.411~416 (2000)
24. Kim HS, "Enhancement of antitumor immunity of dendritic cells pulsed with heat-treated tumor lysate in murine pancreatic cancer", IMMUNOLOGY LETTERS, 103, pp.142~148 (2006), ELSEVIER SCIENCE BV
25. Qiu J, "Heat-shocked tumor cell lysate-pulsed dendritic cells induce effective anti-tumor immune response in vivo", World J Gastroenterol, 12, pp.473~478 (2006)
26. Bachleitner-Hofmann T, "Stimulation of autologous antitumor T-cell responses against medullary thyroid carcinoma using tumor lysate-pulsed dendritic cells", J Clin Endocrinol Metab, 87, pp.1098~1104 (2002)
27. Arnold-Schild D, "Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells", J Immunol, 162, pp.3757~3760 (1999)
28. Babatz J, "Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study", J Hematother Stem Cell Res, 12, pp.515~523 (2003)
29. Santin AD, "Induction of ovarian tumor-specific CD8+ cytotoxic T lymphocytes by acid-eluted peptide-pulsed autologous dendritic cells", Obstet Gynecol, 96, pp.422~430 (2000)
30. Kang D, "Development of non-gel-based two-dimensional separation of intact proteins by an on-line hyphenation of capillary isoelectric focusing and hollow fiber flow field-flow fractionation", ANALYTICAL CHEMISTRY, 78, pp.5789~5798 (2006)
31. Kang D, "Lectin-Based Enrichment Method for Glycoproteomics Using Hollow Fiber Flow Field-Flow Fractionation: Application to Streptococcus pyogenes", JOURNAL OF PROTEOME RESEARCH, 9(6), pp.2855~2862 (2010), AMER CHEMICAL SOC
32. Srivastava PK, "Immunotherapy for human cancer using heat shock protein-peptide complexes", Curr Oncol Rep, 7, pp.104~108 (2005)
33. Salio M, "Dendritic cell maturation is induced by mycoplasma infection but not by necrotic cells", Eur J Immunol, 30, pp.705~708 (2000)
34. Reynolds JL, "Proteomic analyses of the effects of drugs of abuse on monocyte-derived mature dendritic cells", Immunol Invest, 38, pp.526~550 (2009)
35. Reynolds JL, "Proteomic analyses of methamphetamine (METH)-induced differential protein expression by immature dendritic cells (IDC)", Biochim Biophys Acta, 1774, pp.433~442 (2007)
36. Horlock C, "Analysis of proteomic profiles and functional properties of human peripheral blood myeloid dendritic cells, monocyte-derived dendritic cells and the dendritic cell-like KG-1 cells Bhardreveals distinct characteristics", Genome Biol, 8, pp.R30~ (2007)
37. Watarai H, "Plasma membrane-focused proteomics: dramatic changes in surface expression during the maturation of human dendritic cells", Proteomics, 5, pp.4001~4011 (2005)
38. McIlroy D, "Profiling dendritic cell maturation with dedicated microarrays", J Leukoc Biol, 78, pp.794~803 (2005)
39. Pereira SR, "Changes in the proteomic profile during differentiation and maturation of human monocyte-derived dendritic cells stimulated with granulocyte macrophage colony stimulating factor", interleukin-4 and lipopolysaccharide, 2005, pp.5, 1186~1198
40. Rivollier A, "High expression of antioxidant proteins in dendritic cells: possible implications in atherosclerosis", Mol Cell Proteomics, 5, pp.726~736 (2006)
41. Ferret-Bernard S, "Proteomic profiling reveals that Th2-inducing dendritic cells stimulated with helminth antigens have a ‘limited maturation’ phenotype", Proteomics, 8, pp.980~993 (2008)
42. Ferreira GB, "Proteome analysis demonstrates profound alterations in human dendritic cell nature by TX527, an analogue of vitamin D", Proteomics, 9, pp.3752~3764 (2009)
43. Gundacker NC, "Cytoplasmic proteome and secretome profiles of differently stimulated human dendritic cells", J Proteome Res, 8, pp.2799~2811 (2009)
44. Shiwa M, "Rapid discovery and identification of a tissue-specific tumor biomarker from 39 human cancer cell lines using the SELDI ProteinChip platform", Biochem Biophys Res Commun, 309, pp.18~25 (2003)
45. Park T, "Activation of the leukocyte plastin gene occurs in most human cancer cells", Cancer Res, 54, pp.1775~1781 (1994)
46. Shimada H, "Identification of Makorin 1 as a novel SEREX antigen of esophageal squamous cell carcinoma", BMC Cancer, 9, pp.232~ (2009)
47. Li YN, "Glycoprotein nonmetastatic B as a prognostic indicator in small cell lung cancer", APMIS, 122, pp.140~146 (2014)
48. Kabbage M, "Protein alterations in infiltrating ductal carcinomas of the breast as detected by nonequilibrium pH gradient electrophoresis and mass spectrometry", J Biomed Biotechnol, 2008, pp.564127~ (2008)
49. Gongoll S, "Prognostic significance of calcium-binding protein S100A4 in colorectal cancer", Gastroenterology, 123, pp.1478~1484 (2002)
50. Shen J, "Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry", Cancer Res, 64, pp.9018~9026 (2004)
51. Melle C, "Protein profiling of microdissected pancreas carcinoma and identification of HSP27 as a potential serum marker", Clin Chem, 53, pp.629~635 (2007)
52. Nakatsura T, "Cellular and humoral immune responses to a human pancreatic cancer antigen, coactosin-like protein, originally defined by the SEREX method", Eur J Immunol, 32, pp.826~836 (2002)
53. Wang B, "Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors", J Biol Chem, 281, pp.6020~6029 (2006)
54. Rosty C, "Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation", Am J Pathol, 160, pp.45~50 (2002)
55. Celluzzi CM, "Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity", J Exp Med, 183, pp.283~287 (1996)
56. Hoffmann TK, "Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells", Cancer Res, 60, pp.3542~3549 (2000)
57. Gong J, "Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells", Proc Natl Acad Sci U S A, 97, pp.2715~2718 (2000)
58. Ashley DM, "Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors", J Exp Med, 186, pp.1177~1182 (1997)
59. Cranmer LD, "Clinical applications of dendritic cell vaccination in the treatment of cancer", Cancer Immunol Immunother, 53, pp.275~306 (2004)
60. Kammerer R, "Noncovalent association with stress protein facilitates cross-priming of CD8+ T cells to tumor cell antigens by dendritic cells", J Immunol, 168, pp.108~117 (2002)
61. Delneste Y, "Scavenger receptors and heat-shock protein-mediated antigen cross-presentation", Biochem Soc Trans, 32(Pt 4), pp.633~635 (2004)
62. Becker T, "CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes", J Cell Biol, 158, pp.1277~1285 (2002)
63. Basu S, "CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin", Immunity, 14, pp.303~313 (2001)
64. Doody AD, "Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector function", J Immunol, 172, pp.6087~6092 (2004)
65. Wu Y, "Hsp70-like protein 1 fusion protein enhances induction of carcinoembryonic antigen-specific CD8+ CTL response by dendritic cell vaccine", Cancer Res, 65, pp.4947~4954 (2005)
66. Kurotaki T, "Efficient cross-presentation by heat shock protein 90-peptide complex-loaded dendritic cells via an endosomal pathway", J Immunol, 179, pp.1803~1813 (2007)
67. Basu S, "Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway", Int Immunol, 12, pp.1539~1546 (2000)
68. Somersan S, "Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells", J Immunol, 167, pp.4844~4852 (2001)
69. Takakura Y, "Hsp-based tumor vaccines: state-of-the-art and future directions", Curr Opin Mol Ther, 9, pp.385~391 (2007)
70. Feng H, "Stressed apoptotic tumor cells express heat shock proteins and elicit tumor-specific immunity", Blood, 97, pp.3505~3512 (2001)
71. Hashemi SM, "Evaluation of anti-tumor effects of tumor cell lysate enriched by HSP-70 against fibrosarcoma tumor in BALB", c mice, 2007, pp.7, 920~927
72. Urban RG, "A subset of HLA-B27 molecules contains peptides much longer than nonamers", Proc Natl Acad Sci U S A, 91, pp.1534~1538 (1994)
73. Stryhn A, "Longer peptide can be accommodated in the MHC class I binding site by a protrusion mechanism", Eur J Immunol, 30, pp.3089~3099 (2000)
74. Weinschenk T, "Integrated functional genomics approach for the design of patient-individual antitumor vaccines", Cancer Res, 62, pp.5818~5827 (2002)
75. Hickman HD, "Toward a definition of self: proteomic evaluation of the class I peptide repertoire", J Immunol, 172, pp.2944~2952 (2004)
76. Alldinger I, "Gene expression analysis of pancreatic cell lines reveals genes overexpressed in pancreatic cancer", Pancreatology, 5, pp.370~379 (2005)
77. Grønborg M, "Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach", Mol Cell Proteomics, 5, pp.157~171 (2006)
78. Uozumi N, "Identification of a novel type of CA19-9 carrier in human bile and sera of cancer patients: an implication of the involvement in nonsecretory exocytosis", J Proteome Res, 9, pp.6345~6353 (2010)
79. Storr SJ, "Calpain system protein expression in carcinomas of the pancreas, bile duct and ampulla", BMC Cancer, 12, pp.511~ (2012)
80. Ohnami S, "Identification of genes showing differential expression in antisense K-ras-transduced pancreatic cancer cells with suppressed tumorigenicity", Cancer Res, 59, pp.5565~5571 (1999)

관련 논문AI추천